Peripherally Inserted Central Catheters Versus Implanted Port Catheters in Patients with Breast Cancer: a Analysis of the PICCPORT Randomised Controlled Trial

Overview

Journal BJA Open

Specialty Anesthesiology

Date 2025 Feb 24

PMID 39991709

Authors

Anton Utas

Stefanie Seifert

Knut Taxbro

Affiliations

Soon will be listed here.

Abstract

Background: Breast cancer is the most prevalent malignancy affecting women. However, the optimal strategy for patients requiring long-term central venous catheters in breast cancer treatment remains uncertain. Previous investigations involving a mixed cancer population have shown a higher frequency of adverse events among patients receiving peripherally implanted central catheters (PICCs) compared with totally implanted central catheters (PORTs). Our study aimed to compare catheter-related adverse events in breast cancer patients.

Methods: We conducted a analysis of a previously published multicentre RCT known as PICCPORT. Data pertaining to baseline characteristics, insertion specifics, complication rates, and patient satisfaction were collected for breast cancer patients who required long-term central venous catheters for cancer treatment. The primary endpoint was a composite variable encompassing thrombotic, occlusive, infectious, or mechanical complications, while patient satisfaction served as a secondary endpoint.

Results: Our analysis included 80 patients receiving PORT and 78 patients receiving PICC. There was no statistically significant difference in the incidence of complications between the PICC and PORT groups. Interestingly, PICC insertion was less painful than PORT insertion, although both groups reported low levels of pain.

Conclusions: While acknowledging the limitations of an underpowered subgroup analysis, our findings suggest that the well-established superiority of PORTs in terms of adverse events among cancer patients might not be as substantial for breast cancer patients in particular. Ultimately, the optimal strategy for selecting long-term access devices in breast cancer patients remains to be determined.

Clinical Trial Registration: NCT01971021.

References

Kreuziger L, Jaffray J, Carrier M . Epidemiology, diagnosis, prevention and treatment of catheter-related thrombosis in children and adults. Thromb Res. 2017; 157:64-71. DOI: 10.1016/j.thromres.2017.07.002. View

Johansson E, Hammarskjold F, Lundberg D, Heibert Arnlind M . A survey of the current use of peripherally inserted central venous catheter (PICC) in Swedish oncology departments. Acta Oncol. 2013; 52(6):1241-2. DOI: 10.3109/0284186X.2013.806820. View

Sogaard M, Thomsen R, Bossen K, Sorensen H, Norgaard M . The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013; 5(Suppl 1):3-29. PMC: 3820483. DOI: 10.2147/CLEP.S47150. View

Saber W, Moua T, Williams E, Verso M, Agnelli G, Couban S . Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2010; 9(2):312-9. PMC: 4282796. DOI: 10.1111/j.1538-7836.2010.04126.x. View

Pikwer A, Akeson J, Lindgren S . Complications associated with peripheral or central routes for central venous cannulation. Anaesthesia. 2011; 67(1):65-71. DOI: 10.1111/j.1365-2044.2011.06911.x. View

Taxbro K, Hammarskjold F, Thelin B, Lewin F, Hagman H, Hanberger H . Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. Br J Anaesth. 2019; 122(6):734-741. DOI: 10.1016/j.bja.2019.01.038. View

Patel G, Jain K, Kumar R, Strickland A, Pellegrini L, Slavotinek J . Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. Support Care Cancer. 2013; 22(1):121-8. DOI: 10.1007/s00520-013-1941-1. View

Moss J, Wu O, Bodenham A, Agarwal R, Menne T, Jones B . Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet. 2021; 398(10298):403-415. DOI: 10.1016/S0140-6736(21)00766-2. View

Chopra V, OHoro J, Rogers M, Maki D, Safdar N . The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2013; 34(9):908-18. DOI: 10.1086/671737. View

10.

Mermel L, Allon M, Bouza E, Craven D, Flynn P, OGrady N . Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49(1):1-45. PMC: 4039170. DOI: 10.1086/599376. View

11.

Citla Sridhar D, Abou-Ismail M, Ahuja S . Central venous catheter-related thrombosis in children and adults. Thromb Res. 2020; 187:103-112. DOI: 10.1016/j.thromres.2020.01.017. View

12.

Robinson A, Souied O, Bota A, LeVasseur N, Stober C, Hilton J . Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review. Breast Cancer Res Treat. 2018; 171(3):607-620. DOI: 10.1007/s10549-018-4868-x. View

13.

Chopra V, Anand S, Hickner A, Buist M, Rogers M, Saint S . Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013; 382(9889):311-25. DOI: 10.1016/S0140-6736(13)60592-9. View

14.

Lefebvre L, Noyon E, Georgescu D, Proust V, Alexandru C, Leheurteur M . Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients. Support Care Cancer. 2015; 24(3):1397-403. DOI: 10.1007/s00520-015-2901-8. View

15.

Clatot F, Fontanilles M, Lefebvre L, Lequesne J, Veyret C, Alexandru C . Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer. Eur J Cancer. 2020; 126:116-124. DOI: 10.1016/j.ejca.2019.11.022. View

16.

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

17.

Lindgren S, Pikwer A, Ricksten S, Akeson J . Survey of central venous catheterisation practice in Sweden. Acta Anaesthesiol Scand. 2013; 57(10):1237-44. DOI: 10.1111/aas.12190. View